Ken Griffin Neuroone Medical Technologies Corp Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 40,800 shares of NMTC stock, worth $46,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,800Holding current value
$46,920% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NMTC
# of Institutions
21Shares Held
1.62MCall Options Held
40.8KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA920KShares$1.06 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA312KShares$358,4070.0% of portfolio
-
State Street Corp Boston, MA59.5KShares$68,4230.0% of portfolio
-
Blair William & CO Chicago, IL55.6KShares$63,8890.0% of portfolio
-
Mai Capital Management50KShares$57,4990.0% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $18.6M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...